Chronic kidney disease
Overview
•CKD = kidney damage or reduced GFR persisting >3 months
•Paediatric CKD is predominantly structural in origin - unlike adult CKD (diabetes/hypertension)
•Prevalence ~50-75 per million children in the UK; boys affected more than girls
Causes
•CAKUT (congenital anomalies of the kidney and urinary tract) - ~40-50%; renal hypoplasia/dysplasia, posterior urethral valves, vesicoureteric reflux/reflux nephropathy; often detected antenatally
•Glomerulonephritis - FSGS, IgA nephropathy, lupus nephritis
•Hereditary nephropathies - Alport syndrome, polycystic kidney disease
Classification
•Staged by GFR category (G1-G5) and albuminuria category (A1-A3)
•GFR estimated using the Schwartz equation (uses height + serum creatinine) in children
•Normal GFR rises from ~20-30 mL/min/1.73m² at birth to ~90-120 mL/min/1.73m² in early childhood - staging must be age-adjusted
•Albuminuria: A1 = ACR <3 mg/mmol | A2 = ACR 3-30 mg/mmol | A3 = ACR >30 mg/mmol
Presentation
•Early CKD (G1-G2) is frequently asymptomatic - often found incidentally
•Growth failure - key paediatric feature; metabolic acidosis + GH resistance
•Hypertension - up to 50%; sodium/water retention + RAAS activation; may be the presenting finding
•Pallor and fatigue - normochromic normocytic anaemia (reduced EPO)
•Polyuria and polydipsia - impaired concentrating ability; important paediatric clue
•Oedema - nephrotic-range proteinuria or fluid overload in later stages
•Bone pain / rickets - renal osteodystrophy (reduced vitamin D activation + secondary hyperparathyroidism)
•Uraemic symptoms (anorexia, nausea, lethargy) - G4-G5
Investigations
🥇 First-line
•serum creatinine + eGFR (Schwartz equation)
•urine ACR (early morning first-void) - quantifies proteinuria, defines albuminuria category
•renal ultrasound - identifies structural cause; small echogenic kidneys suggest chronicity
•electrolytes + bicarbonate - hyperkalaemia, metabolic acidosis (↓HCO3-), ↑urea in advanced CKD
•FBC - normochromic normocytic anaemia
•calcium, phosphate, PTH, 25-hydroxyvitamin D, alkaline phosphatase - assess CKD-MBD
•urine dipstick and microscopy - haematuria/proteinuria suggest glomerulonephritis; casts are highly informative
🥈 Second-line
•DMSA scintigraphy - differential renal function and cortical scarring (reflux nephropathy)
•MAG3 renogram - obstruction/drainage assessment
•immunology (ANA, ANCA, complement, anti-GBM) - if glomerulonephritis suspected
🏆 Gold standard
•renal biopsy - histological diagnosis where tissue result will change management
Management
•Best delivered through specialist paediatric nephrology MDT (nephrologist, dietitian, specialist nurse, psychologist)
•Blood pressure control - target <50th centile for age/height/sex; ACE inhibitors (e.g. enalapril) or ARBs first-line - reduce glomerular hypertension and proteinuria via RAAS blockade
•Metabolic acidosis - oral sodium bicarbonate to maintain serum bicarbonate ≥22 mmol/L; acidosis drives protein catabolism and worsens growth
•Anaemia - optimise iron stores first (oral/IV iron); if iron-replete anaemia persists, add ESA (darbepoetin alfa)
•CKD-MBD - restrict dietary phosphate; calcium carbonate (calcium-based phosphate binder) with meals; if hypercalcaemia develops, switch to/add sevelamer carbonate (non-calcium-based)
•Vitamin D - alfacalcidol (active 1-alpha vitamin D) - standard vitamin D cannot be hydroxylated by the failing kidney
•Growth failure - correct acidosis and malnutrition first; recombinant human growth hormone (rhGH) in G2-G5 with height below -2 SD after nutritional/metabolic optimisation
•Treat underlying cause - surgical correction of obstructive uropathy, immunosuppression for glomerulonephritis
•Renal replacement therapy (RRT) - G5 or uncontrollable uraemia/fluid overload/electrolyte disturbance; peritoneal dialysis preferred in younger children (home-based); renal transplantation is the optimal long-term option
Complications
Key complications of CKD in children
| Complication | Mechanism | Key management |
|---|---|---|
| Anaemia | ↓ EPO → normochromic normocytic anaemia | Iron then ESA (darbepoetin alfa) |
| CKD-MBD / rickets | Phosphate retention → ↓ active vitamin D → secondary hyperparathyroidism → bone resorption | Phosphate restriction, binders, alfacalcidol |
| Hypertension | Na/water retention + RAAS overactivation → LVH if untreated | ACE inhibitor / ARB |
| Metabolic acidosis | ↓ acid excretion + ↓ HCO3- regeneration; worsens growth and bone disease | Sodium bicarbonate (target HCO3- ≥22 mmol/L) |
| Growth failure | Acidosis, malnutrition, anaemia, osteodystrophy, GH/IGF-1 resistance | Correct metabolic derangements; rhGH if height <-2 SD |
| Hyperkalaemia | Impaired K+ excretion; worsened by ACE inhibitors and high dietary K+ | Dietary restriction; adjust medications |
| Cardiovascular disease | Leading cause of mortality; hypertension, dyslipidaemia, anaemia, hyperphosphataemia | BP control, treat all contributing factors |
Prognosis
•Cardiovascular disease is the leading cause of mortality even in children with CKD
•CAKUT with preserved renal mass - may be stable for years; glomerulonephritis/hereditary nephropathies often progress to G5 in adolescence
•Renal transplantation offers best long-term survival and quality of life; pre-emptive transplantation (before dialysis) associated with superior graft function
•Post-AKI: monitor for at least 3 years even if eGFR returns to baseline (longer for stage 3 AKI) as CKD can develop silently